OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2024
(5)
2022
(4)
2021
(4)
2023
(3)
2014
(2)
2026
(1)
2025
(1)
2016
(1)
2015
(1)
2009
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.
Not available
S-EPMC10911925
|
biostudies-literature
Cite
Neoantigen-targeted CD8
+
T cell responses with PD-1 blockade therapy.
Not available
S-EPMC10441586
|
biostudies-literature
Cite
A contrast between children and adolescents with excellent and poor control: the T1D Exchange clinic registry experience.
Not available
S-EPMC4164957
|
biostudies-literature
Cite
Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium.
Not available
S-EPMC2737177
|
biostudies-literature
Cite
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.
Not available
S-EPMC4938802
|
biostudies-literature
Cite
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Not available
S-EPMC12056793
|
biostudies-literature
Cite
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10831058
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets